suven life sciences' pashamylaram facility successfully completes usfda inspection
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.
.
.
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.
.
.